At a glance
- Originator Egis Pharmaceuticals
- Class Neuroprotectants; Small molecules
- Mechanism of Action AMPA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 02 Jul 2001 No-Development-Reported for Neurological disorders (Prevention) in Hungary (Unknown route)
- 28 Jan 1998 New profile
- 28 Jan 1998 Preclinical development for Neurological disorders (Prevention) in Hungary (Unknown route)